| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00018-007-6527-Y |
| P8608 | Fatcat ID | release_f2rgupss4jg3xmksqraikbdq2a |
| P932 | PMC publication ID | 3383618 |
| P698 | PubMed publication ID | 17364144 |
| P5875 | ResearchGate publication ID | 6443363 |
| P50 | author | Clare M. Lloyd | Q56992813 |
| P2093 | author name string | S G Trivedi | |
| P2860 | cites work | TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma | Q77932791 |
| Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways | Q77950290 | ||
| Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders | Q78177642 | ||
| Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology | Q78396719 | ||
| Airway hyperreactivity in exacerbation of chronic asthma is independent of eosinophilic inflammation | Q79775056 | ||
| Eosinophil-fibroblast interactions induce fibroblast IL-6 secretion and extracellular matrix gene expression: implications in fibrogenesis | Q81321357 | ||
| Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow | Q81395350 | ||
| Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway | Q81672236 | ||
| Injurious effect of the eosinophil peroxide-hydrogen peroxide-halide system and major basic protein on human nasal epithelium in vitro | Q93534392 | ||
| Eosinophils as a potential source of platelet-derived growth factor B-chain (PDGF-B) in nasal polyposis and bronchial asthma | Q93864366 | ||
| Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways | Q22009006 | ||
| Essential and instructive roles of GATA factors in eosinophil development | Q24298723 | ||
| Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23 | Q24303614 | ||
| Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells | Q24312942 | ||
| Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors | Q24313234 | ||
| Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody | Q24561853 | ||
| Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils | Q24562774 | ||
| Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7 | Q24597517 | ||
| Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease | Q24630242 | ||
| Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes | Q24669740 | ||
| Cloning, expression, and characterization of the human eosinophil eotaxin receptor | Q24678271 | ||
| Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation | Q24680123 | ||
| Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity | Q24681943 | ||
| Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. | Q25255561 | ||
| Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit | Q28145386 | ||
| A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse | Q28181927 | ||
| Immune regulation by helminth parasites: cellular and molecular mechanisms | Q28204460 | ||
| Human eosinophils express and release IL-13 following CD28-dependent activation | Q28207371 | ||
| Novel combinatorial interactions of GATA-1, PU.1, and C/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein | Q28219413 | ||
| Interleukin-5, eosinophils, and disease | Q28257501 | ||
| Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand | Q28257968 | ||
| Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia | Q28275791 | ||
| Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro | Q28284666 | ||
| Bertilimumab Cambridge Antibody Technology Group | Q28295955 | ||
| Fusion protein vesicle-associated membrane protein 2 is implicated in IFN-gamma-induced piecemeal degranulation in human eosinophils from atopic individuals | Q30663554 | ||
| Rapid mobilization of intracellularly stored RANTES in response to interferon-gamma in human eosinophils | Q30724124 | ||
| Vanadium stimulates human bronchial epithelial cells to produce heparin-binding epidermal growth factor-like growth factor: a mitogen for lung fibroblasts | Q31834419 | ||
| Airway remodeling in asthma | Q33753444 | ||
| Eotaxin: from an eosinophilic chemokine to a major regulator of allergic reactions. | Q33756004 | ||
| Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm. | Q33768110 | ||
| Mechanisms of eosinophil-associated inflammation | Q33886210 | ||
| Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor | Q33894905 | ||
| Human eosinophils produce biologically active IL-12: implications for control of T cell responses | Q41029744 | ||
| Synthesis of type 1 (IFN gamma) and type 2 (IL-4, IL-5, and IL-10) cytokines by human eosinophils | Q41200709 | ||
| Regulation of type I collagen mRNA translation by TGF-beta. | Q41557482 | ||
| Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig | Q41744147 | ||
| Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release. | Q41839803 | ||
| Requirement for IL-13 independently of IL-4 in experimental asthma | Q41881960 | ||
| Activation of basophil and mast cell histamine release by eosinophil granule major basic protein | Q41991407 | ||
| Effects of steroid treatment on lung CC chemokines, apoptosis and transepithelial cell clearance during development and resolution of allergic airway inflammation. | Q42225465 | ||
| The Coordinated Action of CC Chemokines in the Lung Orchestrates Allergic Inflammation and Airway Hyperresponsiveness | Q42417164 | ||
| Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics. | Q42511110 | ||
| Eosinophils expressing heparin-binding EGF-like growth factor mRNA localize around lung microvessels in pulmonary hypertension | Q42754437 | ||
| Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia | Q42947733 | ||
| TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice | Q43059347 | ||
| Regulation of lymphocyte proliferation by eosinophils via chymotrypsin-like protease activity and adhesion molecule interaction | Q43264612 | ||
| Receptor internalization is required for eotaxin-induced responses in human eosinophils | Q44281045 | ||
| Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alph | Q44448872 | ||
| Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation | Q44518704 | ||
| Compound exocytosis and cumulative fusion in eosinophils | Q44552155 | ||
| Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice | Q44771554 | ||
| Interleukin-13 Induces Proliferation of Human Airway Epithelial CellsIn Vitrovia a Mechanism Mediated by Transforming Growth Factor- α | Q44876815 | ||
| Allergen stimulates bone marrow CD34(+) cells to release IL-5 in vitro; a mechanism involved in eosinophilic inflammation? | Q45050078 | ||
| 2B4 (CD244) is expressed and functional on human eosinophils | Q45195916 | ||
| Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle | Q45270945 | ||
| Inhibition of eosinophil rolling and recruitment in P-selectin- and intracellular adhesion molecule-1-deficient mice | Q46233274 | ||
| Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency. | Q46383173 | ||
| Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein | Q46502189 | ||
| Conserved structure and tissue expression of rat eotaxin | Q46847625 | ||
| Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation | Q46913829 | ||
| The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo | Q46987094 | ||
| Effects of a low-molecular-weight CCR-3 antagonist on chronic experimental asthma | Q47325098 | ||
| A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5 | Q47756902 | ||
| Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge | Q47803593 | ||
| Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge. | Q47821478 | ||
| Airway remodelling in asthma: models and supermodels? | Q47845487 | ||
| Markers of eosinophilic inflammation and tissue re-modelling in children before clinically diagnosed bronchial asthma | Q47853684 | ||
| Increased eosinophil-lineage committed progenitors in the lung of allergen-challenged mice | Q47869342 | ||
| A critical role for eosinophils in allergic airways remodeling | Q47925478 | ||
| Defining a link with asthma in mice congenitally deficient in eosinophils. | Q47925494 | ||
| Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics | Q47963812 | ||
| Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response | Q48067938 | ||
| Role of ADAM8 in experimental asthma | Q48774746 | ||
| Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. | Q49032278 | ||
| SNARE proteins are critical for regulated exocytosis of ECP from human eosinophils | Q49064640 | ||
| IL-11 expression is increased in severe asthma: association with epithelial cells and eosinophils | Q50232593 | ||
| Nerve growth factor is preformed in and activates human peripheral blood eosinophils | Q50522335 | ||
| Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps | Q50772939 | ||
| CC Chemokine Ligand 1 Promotes Recruitment of Eosinophils But Not Th2 Cells During the Development of Allergic Airways Disease | Q51676560 | ||
| Mast-cell infiltration of airway smooth muscle in asthma | Q51715332 | ||
| Identification of interleukin-2 in human peripheral blood eosinophils | Q52519848 | ||
| The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia | Q53654624 | ||
| Regulation of B lymphocyte and macrophage development by graded expression of PU.1. | Q55033922 | ||
| Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. | Q55034563 | ||
| Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects | Q55094051 | ||
| Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha | Q56752153 | ||
| Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function? | Q36239677 | ||
| Eosinophilia in transgenic mice expressing interleukin 5. | Q36353850 | ||
| The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma | Q36357991 | ||
| Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo | Q36365726 | ||
| Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model | Q36366104 | ||
| Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. | Q36366158 | ||
| Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo | Q36369717 | ||
| Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma | Q36369722 | ||
| T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro | Q36375111 | ||
| CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo | Q36375742 | ||
| Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma | Q36377337 | ||
| Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo | Q36380566 | ||
| Mechanisms of Acute Eosinophil Mobilization from the Bone Marrow Stimulated by Interleukin 5: The Role of Specific Adhesion Molecules and Phosphatidylinositol 3-Kinase | Q36401641 | ||
| Eosinophilic airway disorders | Q36448420 | ||
| The asthma epidemic | Q36662046 | ||
| Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis | Q36853612 | ||
| Lymph node trafficking and antigen presentation by endobronchial eosinophils | Q37176309 | ||
| Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors | Q37361509 | ||
| Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice | Q37364684 | ||
| High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. | Q37371775 | ||
| Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation | Q37374729 | ||
| Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice | Q37380666 | ||
| Myofibroblasts differentiate from fibroblasts when plated at low density | Q37633281 | ||
| Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma | Q40210092 | ||
| Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells | Q40230341 | ||
| Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase | Q40495420 | ||
| Inhibition of airway remodeling in IL-5-deficient mice | Q40553706 | ||
| Inhibitory role of eosinophils on cell surface plasmin generation by bronchial epithelial cells: inhibitory effects of transforming growth factor beta | Q40789221 | ||
| CC chemokine receptor-3 undergoes prolonged ligand-induced internalization | Q40959278 | ||
| Asthma. From bronchoconstriction to airways inflammation and remodeling | Q33915771 | ||
| Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression | Q33941230 | ||
| New aspects of degranulation and fates of airway mucosal eosinophils | Q33942417 | ||
| Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease | Q33943245 | ||
| The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness | Q34009861 | ||
| IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines | Q34090258 | ||
| Human eosinophils express functional interleukin 2 receptors | Q34197541 | ||
| Elemental signals regulating eosinophil accumulation in the lung. | Q34211465 | ||
| IL-5-induced airway eosinophilia--the key to asthma? | Q34211474 | ||
| Expression of membrane type-4 matrix metalloproteinase (metalloproteinase-17) by human eosinophils | Q34228911 | ||
| Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins | Q34250409 | ||
| Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation | Q34326460 | ||
| Eosinophils function as antigen-presenting cells | Q34329153 | ||
| The trials and tribulations of IL-5, eosinophils, and allergic asthma | Q34394617 | ||
| The eosinophil | Q34503956 | ||
| Making eosinophils through subtle shifts in transcription factor expression | Q34667489 | ||
| Localized eosinophil degranulation mediates disease in tropical pulmonary eosinophilia | Q34713307 | ||
| Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation | Q34825566 | ||
| Inflammatory cells in asthma: mechanisms and implications for therapy | Q35047387 | ||
| Airway hyperresponsiveness | Q35082509 | ||
| Understanding exocytosis in immune and inflammatory cells: the molecular basis of mediator secretion | Q35126066 | ||
| A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation | Q35133853 | ||
| Eosinophils and cysteinyl leukotrienes. | Q35190750 | ||
| Chemokines in allergic airway disease. | Q35193668 | ||
| Purification of human eosinophil-derived neurotoxin | Q35468177 | ||
| Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha | Q35611042 | ||
| The role of eosinophils in host defense against helminth parasites | Q35624885 | ||
| Time to draw breath: asthma-susceptibility genes are identified | Q35773264 | ||
| Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair | Q35932924 | ||
| Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice | Q35955690 | ||
| Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics | Q36001230 | ||
| Enhanced upregulation of smooth muscle related transcripts by TGF beta2 in asthmatic (myo) fibroblasts | Q36183983 | ||
| Prolonged allergen challenge in mice leads to persistent airway remodelling. | Q36193173 | ||
| Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system | Q36228614 | ||
| Epithelial-mesenchymal communication in the pathogenesis of chronic asthma | Q36236793 | ||
| PDGF-A Signaling Is a Critical Event in Lung Alveolar Myofibroblast Development and Alveogenesis | Q57415025 | ||
| Increases in eotaxin-positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challenge | Q57415813 | ||
| The Relationship Between Allergen-Induced Tissue Eosinophilia and Markers of Repair and Remodeling in Human Atopic Skin | Q57966311 | ||
| Eosinophil cationic protein alters proteoglycan metabolism in human lung fibroblast cultures | Q68003083 | ||
| Human eosinophils synthesize and secrete interleukin-6, in vitro | Q68039348 | ||
| Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma | Q68052191 | ||
| In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals | Q68090195 | ||
| T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma | Q68294272 | ||
| Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins | Q69351581 | ||
| Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma | Q70770268 | ||
| Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein | Q70911250 | ||
| Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients | Q71046247 | ||
| Strongyloides stercoralis: eosinophil-dependent immune-mediated killing of third stage larvae in BALB/cByJ mice | Q71080603 | ||
| Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils | Q71120610 | ||
| Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES | Q71483496 | ||
| Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions | Q71611722 | ||
| Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch | Q71644388 | ||
| Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein | Q71692466 | ||
| Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects | Q71778422 | ||
| Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia | Q71994193 | ||
| Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils | Q72056200 | ||
| IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma | Q72191734 | ||
| Pretreatment with an antibody to interleukin-5 prevents loss of pulmonary M2 muscarinic receptor function in antigen-challenged guinea pigs | Q72584587 | ||
| Eosinophil major basic protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma | Q73163088 | ||
| Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells | Q73202021 | ||
| Expression and regulation of monocyte chemoattractant protein-1 by human eosinophils | Q73295944 | ||
| Resolution of bronchial hyperresponsiveness and pulmonary inflammation is associated with IL-3 and tissue leukocyte apoptosis | Q73400847 | ||
| Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis | Q73431447 | ||
| Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function | Q73575778 | ||
| Interleukin-2 inhibits eosinophil migration but is counteracted by IL-5 priming | Q73622099 | ||
| Eosinophil-associated TGF- β1mRNA Expression and Airways Fibrosis in Bronchial Asthma | Q73728083 | ||
| Release of RANTES, MIP-1 α , and MCP-1 into Asthmatic Airways Following Endobronchial Allergen Challenge | Q73885831 | ||
| Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9 | Q73893710 | ||
| The chemotactic cytokine eotaxin acts as a granulocyte-macrophage colony-stimulating factor during lung inflammation | Q74270275 | ||
| Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow | Q74357254 | ||
| Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma | Q74417771 | ||
| Eosinophils promote allergic disease of the lung by regulating CD4(+) Th2 lymphocyte function | Q74481539 | ||
| The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma | Q74595761 | ||
| Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells | Q74595805 | ||
| Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG | Q74595915 | ||
| Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation | Q75424883 | ||
| Intracellular localization and release of eotaxin from normal eosinophils | Q77317884 | ||
| IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts | Q77492715 | ||
| CD34(+)/interleukin-5Ralpha messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors | Q77742474 | ||
| The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils | Q77784712 | ||
| P433 | issue | 10 | |
| P921 | main subject | pathogenesis | Q372016 |
| P304 | page(s) | 1269-1289 | |
| P577 | publication date | 2007-05-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Cellular and Molecular Life Sciences | Q5058352 |
| P1476 | title | Eosinophils in the pathogenesis of allergic airways disease | |
| P478 | volume | 64 |
| Q37685898 | A possible role for neutrophils in allergic rhinitis revealed after cellular subclassification |
| Q36509887 | Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells |
| Q33598646 | Allergies and diabetes as risk factors for dengue hemorrhagic fever: results of a case control study |
| Q34133884 | An ovine tracheal explant culture model for allergic airway inflammation |
| Q44795042 | CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2. |
| Q37885396 | Can anti-IgE therapy prevent airway remodeling in allergic asthma? |
| Q46730237 | Cellular and cytokine responses associated with dinitrofluorobenzene-induced contact hypersensitivity in the chicken |
| Q34073570 | Chronic inflammation and asthma |
| Q36925306 | Electron tomography and immunonanogold electron microscopy for investigating intracellular trafficking and secretion in human eosinophils |
| Q51584087 | Eosinophilic airway inflammation in a cynomolgus monkey |
| Q39885996 | Eosinophilic inflammation in allergic asthma. |
| Q35830795 | Eosinophilic oesophagitis: clinical presentation and pathogenesis |
| Q28393919 | Eosinophils in fungus-associated allergic pulmonary disease |
| Q35717319 | Eosinophils in glioblastoma biology |
| Q37071247 | Ethyl pyruvate attenuates murine allergic rhinitis partly by decreasing high mobility group box 1 release |
| Q47222770 | Evidence for ligand-specific conformations of the histamine H2-receptor in human eosinophils and neutrophils |
| Q35118946 | GM-CSF production by glioblastoma cells has a functional role in eosinophil survival, activation, and growth factor production for enhanced tumor cell proliferation |
| Q39181829 | Host lung immunity is severely compromised during tropical pulmonary eosinophilia: role of lung eosinophils and macrophages |
| Q35579991 | Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B |
| Q37056435 | Human eosinophils express functional CCR7. |
| Q90411761 | Hydro-Ethanolic Extract of Portulaca Oleracea Ameliorates Total and Differential WBC, Lung Pathology and Oxidative Biomarkers in Asthmatic Rats |
| Q84698017 | IL-33 Exacerbates Eosinophil-Mediated Airway Inflammation |
| Q34326427 | IL-4 engagement of the type I IL-4 receptor complex enhances mouse eosinophil migration to eotaxin-1 in vitro |
| Q36506971 | IL-8, IL-10, TGF-β, and GCSF Levels Were Increased in Severe Persistent Allergic Asthma Patients with the Anti-IgE Treatment |
| Q37709524 | Immune cells in liver regeneration |
| Q53373297 | Increased plasma reactive oxidant levels and their relationship to blood cells, total IgE, and allergen-specific IgE levels in asthmatic children |
| Q36178397 | Inflammatory Mediators in Induced Sputum and Airway Hyperresponsiveness in Cough Variant Asthma during Long-Term Inhaled Corticosteroid Treatment |
| Q43118332 | Inhibitory Action of Quercetin on Eosinophil ActivationIn Vitro |
| Q36929586 | Innate immunity and aging |
| Q38819029 | Interaction Between Helminths and Toll-Like Receptors: Possibilities and Potentials for Asthma Therapy |
| Q41095525 | Maternal obesity alters immune cell frequencies and responses in umbilical cord blood samples |
| Q36944424 | Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins |
| Q38194031 | Mitochondria in the center of human eosinophil apoptosis and survival |
| Q53214514 | NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists |
| Q37975547 | Pattern-recognition receptors in human eosinophils |
| Q37668864 | Phosphatidylinositol 3-kinase isoforms as targets in respiratory disease. |
| Q36188927 | Piecemeal degranulation in human eosinophils: a distinct secretion mechanism underlying inflammatory responses |
| Q50000630 | Progress in the understanding of the pathology of allergic asthma and the potential of fruit proanthocyanidins as modulators of airway inflammation |
| Q30435871 | Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease |
| Q38094691 | RAGE regulation and signaling in inflammation and beyond. |
| Q79671030 | Recruitment of CD34+ progenitor cells into peripheral blood and asthma severity |
| Q39377433 | Regulation of Eosinophil Recruitment and Activation by Galectins in Allergic Asthma |
| Q38256352 | Regulation of spontaneous eosinophil apoptosis-a neglected area of importance |
| Q93081762 | Severe Eosinophilic Asthma |
| Q34594373 | Symptom Score for Allergic Rhinitis |
| Q37832529 | Targeting chemokine receptors in allergic disease |
| Q37056577 | Targeting eosinophils in asthma |
| Q36147533 | Tbet Deficiency Causes T Helper Cell Dependent Airways Eosinophilia and Mucus Hypersecretion in Response to Rhinovirus Infection. |
| Q38707472 | The Role and Immunobiology of Eosinophils in the Respiratory System: a Comprehensive Review |
| Q28654995 | The normative value of inflammatory cells in the nasal perfusate of Chinese adults: a pilot study |
| Q54424154 | Up-regulation of Orai1 in murine allergic rhinitis |
| Q43105476 | Vesicle-mediated secretion of human eosinophil granule-derived major basic protein. |
| Q35807045 | p-STAT6, PU.1, and NF-κB are involved in allergen-induced late-phase airway inflammation in asthma patients |
| Q34548841 | γδT cells regulate chronic airway inflammation and development of airway remodelling. |
Search more.